Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants
Aluminium Foil as an Adjuvant to Phototherapy for Pathological Unconjugated Hyperbilirubinaemia in Full Term Infants
prospective single center pilot randomized open label clinical trial, conducted at the
 Neonatal care unit of Mansoura University Children's To assess the efficacy and safety of
 aluminum foil use in combination with phototherapy compared with phototherapy alone for
 pathological unconjugated hyperbilirubinaemia in full term newborn We enrolled 234 infants in
 the study who fulfilled the inclusion criteria and were randomly assigned to treatment
 groups, either conventional phototherapy with aluminum foil or conventional phototherapy
 alone.
Inclusion Criteria:

 -  Appropriate for gestational age full-term infants with pathological unconjugated
 hyperbilirubinaemia who are candidate for photo therapy according to American academy
 guidelines

 Exclusion Criteria:

 -  Preterm infants, newborn infant with congenital malformations, conjugated
 hyperbilirubinamia, small for gestational age, in need of exchange transfusion, and
 skin abrasions or infections